This bill provides fiscal year 2026 appropriations for Agriculture, Rural Development, the FDA, Military Construction, and Veterans Affairs, while also extending numerous existing programs across various agencies through early 2026.
Tom Cole
Representative
OK-4
This bill provides the necessary appropriations for the Agriculture, Rural Development, Food and Drug Administration, and related agencies for Fiscal Year 2026. It funds ongoing government operations while also including numerous extensions for expiring programs across health, Medicare, and veterans' affairs sectors. Additionally, the legislation contains several specific policy directives, including restrictions on federal workforce reductions and provisions related to agricultural trade and FDA user fees.
| Party | Total Votes | Yes | No | Did Not Vote |
|---|---|---|---|---|
Democrat | 259 | 13 | 245 | 1 |
Republican | 272 | 268 | 3 | 1 |
Independent | 2 | 1 | 1 | 0 |
Here’s the deal: Congress just dropped a massive, multi-division spending bill—the kind that keeps the lights on across half the federal government. Officially called the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026, this isn't just one bill; it’s a stack of funding and program extensions rolled into one. For most of us, this means stability, but it also comes with some serious procedural moves that are worth paying attention to.
First and foremost, this bill acts as a Continuing Resolution (CR) for many agencies, essentially funding them through Fiscal Year 2026 at the same rates they had in 2025. This is the government’s way of saying, “Keep doing what you’re doing, but don’t start anything new.” It ensures that federal services don't shut down, but it puts a hard freeze on any agency trying to expand or launch new initiatives, especially within the Department of Defense. On the flip side, it also prohibits the federal government from announcing or implementing any plan to reduce the size of the civilian workforce until the CR expires, which is a temporary win for job security for federal employees.
If you rely on certain government services, the biggest takeaway here is the stability this bill provides by extending dozens of existing programs, often through September 30, 2026. Think of it as a policy security blanket.
Not everything in this bill is about continuing the status quo. Two provisions stand out because they change how things are paid for and how Congress operates behind the scenes.
First, Division F establishes the Over-the-Counter Monograph Drug User Fee Amendments. Translation: The FDA is now authorized to charge fees to the companies that make OTC drugs (like Tylenol, antacids, and cough syrup) to fund the agency’s regulatory oversight. This is a classic shift—moving the cost of regulation from the taxpayer to the industry. While it’s designed to make the FDA more efficient, those fees are ultimately a new cost for drug manufacturers, which could eventually be passed along to you at the pharmacy counter.
Second, there’s a procedural move that impacts how funding is interpreted. Section 4 states that a single explanatory statement, submitted by the Senate Appropriations Committee Chair, will carry the same legal weight as a formal, bipartisan conference committee report when it comes to directing how funds are spent for Divisions B through D. This centralizes a huge amount of interpretive power in one person’s hands, allowing that single document to dictate exactly how billions of dollars are allocated and implemented across agriculture, the legislative branch, and the military/VA.
The most significant, yet most technical, part of this bill is found in Division H, which deals with budget rules. This section explicitly exempts the budgetary effects of several massive divisions (D, E, F, and H itself) from standard budget scorekeeping rules, specifically the “Statutory Pay-As-You-Go” (PAYGO) scorecards.
PAYGO is a rule designed to ensure that if Congress passes new spending or tax cuts, it must offset the cost elsewhere. By exempting these divisions, Congress is essentially saying, “We’re spending and extending these programs, but we don’t want the cost to count against our budget limits.” Furthermore, the bill resets the balances on the PAYGO scorecards to zero. While this move is often used to clear the decks for future legislation, it means that the true fiscal impact of these multi-billion-dollar extensions is deliberately masked from the standard accountability mechanisms designed to track the national debt. It’s a procedural maneuver that allows for a lot of spending without the typical budgetary consequences showing up on the official scorecards.